Published data on the clinical use of emicizumab in people with hemophilia A with or without factor VIII inhibitors are available. This website includes select scientific data and published studies with the strongest and most relevant information. Click on the below topics to learn more:
Clinical Trials
Quality of Life
Safety
Patient Management Topics
Long-Term Data
Additional Topics
For questions regarding access to full journal publications describing emicizumab, please access our medicine information support.